For the Inventor, By the Inventor

Enter assignee name

Austin, TX, United States of America

Zimmer Orthobiologics, Inc.

Calculating rank

USPTO Granted Patents = 26

% Expired Patents = 73.1

EPO Patents = 5

Forward Citations = 411

Loading Chart...

Loading Chart...

37 inventors (with patents filed for the assignee):

Rama Akella (8 out of 10 patents)

Kevin Thorne (7 out of 7 patents)

John Paul Ranieri (7 out of 16 patents)

4. Victor Zaporojan (4 out of 7 patents)

5. Jian Yao (3 out of 77 patents)

6. Daniel Nadler (2 out of 4 patents)

7. Hali Wang (2 out of 7 patents)

8. Peter Bittmann (2 out of 6 patents)

9. Jörg Auer (2 out of 2 patents)

10. Pedro Bittmann (2 out of 6 patents)

11. James John Benedict (2 out of 13 patents)

12. Jian Yao (1 out of 49 patents)

13. Hai Bo Wen (1 out of 4 patents)

14. Shuliang Li (1 out of 2 patents)

15. Jizong Gao (1 out of 4 patents)

Core Competencies:

Connective Tissue

Cartilage Defects

Bone Growth

Osteoinductive Proteins

Medical Devices

Tissue Surface Repair

Bone Void Fillers

Suturing Techniques

Implantable Materials

Wound Healing

Prosthetic Grafts

Angiogenesis

26 patents: Sort by Forward Citations

1. 9339587 - Composition and methods for repair of connective tissue (2016-05-17),

2. 8945535 - Implant for the repair of a cartilage defect and method for manufacturing the implant (2015-02-03),

3. 8829166 - Rapid isolation of osteoinductive protein mixtures from mammalian bone tissue (2014-09-09),

4. 8801725 - Instruments and methods used when repairing a defect on a tissue surface (2014-08-12),

5. 8742072 - Bone growth particles and osteoinductive composition thereof (2014-06-03),

6. 8690874 - Composition and process for bone growth and repair (2014-04-08),

7. 8613938 - Bone void fillers (2013-12-24),

8. 8608759 - Medical devices for suturing biological tissue (2013-12-17),

9. 8497236 - Implantable putty material (2013-07-30),

10. 8497121 - Method of obtaining viable small tissue particles and use for tissue repair (2013-07-30),

11. RE43714 - Preparation for repairing cartilage defects or cartilage/bone defects in human or animal joints (2012-10-01),

12. 8173162 - Preparation for repairing cartilage tissue, especially articular cartilage defects (2012-05-08),

13. 8163549 - Method of obtaining viable small tissue particles and use for tissue repair (2012-04-24),

14. 7847072 - Rapid isolation of osteoinductive protein mixtures from mammalian bone tissue (2010-12-07),

15. 7718616 - Bone growth particles and osteoinductive composition thereof (2010-05-18),

Company Overview

Zimmer Orthobiologics, Inc. specializes in the development and manufacturing of innovative solutions for orthopedic and musculoskeletal health. The company focuses on advanced biologic products that enhance healing and recovery processes in patients undergoing orthopedic procedures. With a commitment to research and development, Zimmer Orthobiologics aims to improve patient outcomes through cutting-edge technologies and therapies, serving healthcare providers and patients primarily in the United States and beyond.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

26 Patents

#116 in Austin, TX

#739 in Texas

#12,875 in US

#24,848 in the World

Austin, TX, United States of America

Zimmer Orthobiologics, Inc.

Forward Citations = 411

37 inventors:

Rama Akella (8 out of 10 patents)

Kevin Thorne (7 out of 7 patents)

John Paul Ranieri (7 out of 16 patents)

4. Victor Zaporojan (4 out of 7 patents)

5. Jian Yao (3 out of 77 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Zimmer Orthobiologics, Inc.. Retrieved from https://idiyas.com/company/zimmer-orthobiologics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…